| Literature DB >> 10952425 |
M M Koerner1, J B Durand, J A Lafuente, G P Noon, G Torre-Amione.
Abstract
End-stage heart failure is still associated with a decrease in quality and prognosis of life. Cardiac transplantation remains the final extraordinary therapeutic option for the treatment of truly irreversible end-stage heart failure in all age groups. The selection process of candidates and the acceptance of patients with relative contra-indications is characterized by the experience and skills of an interdisciplinary transplant team, which should have access to different mechanical circulatory support systems for short-term or long-term use: bridging to transplant as well as for recovery.Entities:
Mesh:
Year: 2000 PMID: 10952425 DOI: 10.1097/00001573-200005000-00010
Source DB: PubMed Journal: Curr Opin Cardiol ISSN: 0268-4705 Impact factor: 2.161